Theratechnologies Inc. (TSE:TH – Get Free Report)’s stock price shot up 1.9% during trading on Thursday . The stock traded as high as C$2.21 and last traded at C$2.18. 37,126 shares traded hands during trading, a decline of 12% from the average session volume of 42,232 shares. The stock had previously closed at C$2.14.
Theratechnologies Price Performance
The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64. The company’s 50-day simple moving average is C$2.39 and its 200-day simple moving average is C$1.98. The company has a market cap of C$105.75 million, a price-to-earnings ratio of -12.78, a P/E/G ratio of -8.50 and a beta of 1.73.
About Theratechnologies
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Further Reading
- Five stocks we like better than Theratechnologies
- What is a Special Dividend?
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 02/03 – 02/07
- What is an Earnings Surprise?
- Meta Platforms Continues to Prove Why It’s a Premier Play on AI
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
